Last reviewed · How we verify

NCT04660162: LACOM

Comparison of Laser Speckle Contrast Imaging and Laser Doppler Imaging

Completed NA Last updated 17 March 2023
What this trial tests

NA trial testing Iontophoresis in Microcirculation in 15 participants. Completed in 17 December 2018.

Timeline
10 December 2018
Primary endpoint
17 December 2018
17 December 2018

Quick facts

Lead sponsorMaasstad Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designsequential
Maskingnone
Primary purposescreening
Enrollment15
Start date10 December 2018
Primary completion17 December 2018
Estimated completion17 December 2018
Sites1 location across Netherlands

Drugs / interventions tested

Conditions studied

Sponsor

Maasstad Hospital

Who can join

Adults 18 to 50, any sex, with Microcirculation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The microcirculation plays a fundamental role in metabolic reactions and has been shown as an essential determinant in many clinical scenarios such as shock states, chronic and cardio-metabolic diseases. Microcirculation can be assessed directly using laser-based techniques and intravital microscopes. When combined with provocation tests, microvascular monitorization can be used to assess microvascular function. Laser-based techniques are consist of two different methods named laser doppler imaging (LDI), laser speckle contrast imaging (LSCI). LSCI is a technique based on speckle contrast analysis that provides an index of blood flux. No need for skin contact, continuous and real-time assessment of the microcirculation led the LSCI to be broadly used in clinical practice. LDI is also a non-invasive diagnostic method used to measure the blood flux of tissue. The technique is based on measuring the doppler shift induced by moving red blood cells to the illuminating coherent light. Iontophoresis is one of the most commonly used provocation tests to study the endothelium in terms of endothelium-dependent and endothelium-independent vasodilation. Simultaneously with LDI and LSCI are used to follow and assess the skin blood flux during iontophoresis. Therefore, it provides a state to make a comparison between two different laser-based techniques in terms of flux characteristics. The accurate assessment of burn depth is a critical step in the management of the burn-injured patient. Currently, LDI is the most widely used non-invasive measurement tool for assessing burn wounds and the only technique approved by the U.S. Food and Drug Administration. However, the LDI device is rather costly, cumbersome, and has a poor spatial resolution. LSCI measures perfusion in a similar way, but it provides high-quality images with a much higher spatial resolution. In addition, LSCI is much quicker, maneuverable, and able to assess larger skin areas. In order to use the LSCI technique in the clinical practice of burn-injured patients, as a first step, the linearity of LDI and LSCI should be shown. In this study, we aimed to compare LSCI and LDI with iontophoresis and stepwise occlusion technique. So, we will test the linearity of devices over a large range of blood flux values.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Comparison of laser speckle contrast imaging with laser Doppler perfusion imaging for tissue perfusion measurement.
    Guven G, Dijkstra A, Kuijper TM, Trommel N, et al · · 2023 · cited 10× · PMID 36524297 · DOI 10.1111/micc.12795

Verify or expand the search:

Other trials of Iontophoresis

Trials testing the same drug.

Other recruiting trials for Microcirculation

Currently open trials in the same condition.

Other Maasstad Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04660162.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing